Cargando…
The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up
PURPOSE: No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across pharmacies, patients and clinicians will face challenges accessing affordable medications when refilling medications. This is especially pertinent t...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745713/ https://www.ncbi.nlm.nih.gov/pubmed/36512134 http://dx.doi.org/10.1007/s00520-022-07472-x |
_version_ | 1784849208713412608 |
---|---|
author | Etteldorf, Andrew Sedhom, Ramy Rotolo, Shannon M. Vogel, Rachel I. Booth, Christopher M. Blaes, Anne H. Virnig, Beth A. Dusetzina, Stacie B. Gupta, Arjun |
author_facet | Etteldorf, Andrew Sedhom, Ramy Rotolo, Shannon M. Vogel, Rachel I. Booth, Christopher M. Blaes, Anne H. Virnig, Beth A. Dusetzina, Stacie B. Gupta, Arjun |
author_sort | Etteldorf, Andrew |
collection | PubMed |
description | PURPOSE: No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across pharmacies, patients and clinicians will face challenges accessing affordable medications when refilling medications. This is especially pertinent to people with cancer with multiple fills of supportive care medications over time. We evaluated if the lowest-priced pharmacy for a formulation remains the lowest-priced over time. METHODS: We compiled generic medications used to manage nausea/vomiting (14 formulations) and anorexia/cachexia (12 formulations). We extracted discounted prices in October 2021 and again in March 2022 for a typical fill at 8 pharmacies in Minneapolis, Minnesota, USA (zip code 55,414) using GoodRx.com. We examined how prices changed across formulations and pharmacies over time. RESULTS: Data were available for all 208 possible pharmacy-formulation combinations (8 pharmacies × 26 formulations). For 172 (83%) of the 208 pharmacy-formulation combinations, the March 2022 price was within 20% of the October 2021 price. Across pharmacy-formulation combinations, the price change over time ranged from − 76 to + 292%. For 12 (46%) of the 26 formulations, at least one pharmacy with the lowest price in October 2021 no longer was the least costly in March 2022. For one formulation (dronabinol tablets), the least expensive pharmacy became the most expensive, with an absolute and relative price increase of a fill of $22 and 85%. CONCLUSION: For almost half of formulations studied, at least one pharmacy with the lowest price was no longer the least costly a few months later. The lowest price for a formulation (across pharmacies) could also change considerably. Thus, even if a patient accesses the least expensive pharmacy for a medication, they may need to re-check prices across all pharmacies with each subsequent fill to access the lowest prices. In addition to safety concerns, directing medications to and accessing medications at multiple pharmacies can add time and logistic toxicity to patients with cancer, their care partners, prescribers, and pharmacy teams. |
format | Online Article Text |
id | pubmed-9745713 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Springer Berlin Heidelberg |
record_format | MEDLINE/PubMed |
spelling | pubmed-97457132022-12-13 The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up Etteldorf, Andrew Sedhom, Ramy Rotolo, Shannon M. Vogel, Rachel I. Booth, Christopher M. Blaes, Anne H. Virnig, Beth A. Dusetzina, Stacie B. Gupta, Arjun Support Care Cancer Research PURPOSE: No single pharmacy in an urban zip code is consistently the least expensive across medications. If medication prices change differently across pharmacies, patients and clinicians will face challenges accessing affordable medications when refilling medications. This is especially pertinent to people with cancer with multiple fills of supportive care medications over time. We evaluated if the lowest-priced pharmacy for a formulation remains the lowest-priced over time. METHODS: We compiled generic medications used to manage nausea/vomiting (14 formulations) and anorexia/cachexia (12 formulations). We extracted discounted prices in October 2021 and again in March 2022 for a typical fill at 8 pharmacies in Minneapolis, Minnesota, USA (zip code 55,414) using GoodRx.com. We examined how prices changed across formulations and pharmacies over time. RESULTS: Data were available for all 208 possible pharmacy-formulation combinations (8 pharmacies × 26 formulations). For 172 (83%) of the 208 pharmacy-formulation combinations, the March 2022 price was within 20% of the October 2021 price. Across pharmacy-formulation combinations, the price change over time ranged from − 76 to + 292%. For 12 (46%) of the 26 formulations, at least one pharmacy with the lowest price in October 2021 no longer was the least costly in March 2022. For one formulation (dronabinol tablets), the least expensive pharmacy became the most expensive, with an absolute and relative price increase of a fill of $22 and 85%. CONCLUSION: For almost half of formulations studied, at least one pharmacy with the lowest price was no longer the least costly a few months later. The lowest price for a formulation (across pharmacies) could also change considerably. Thus, even if a patient accesses the least expensive pharmacy for a medication, they may need to re-check prices across all pharmacies with each subsequent fill to access the lowest prices. In addition to safety concerns, directing medications to and accessing medications at multiple pharmacies can add time and logistic toxicity to patients with cancer, their care partners, prescribers, and pharmacy teams. Springer Berlin Heidelberg 2022-12-13 2023 /pmc/articles/PMC9745713/ /pubmed/36512134 http://dx.doi.org/10.1007/s00520-022-07472-x Text en © The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature 2022, Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law. This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Research Etteldorf, Andrew Sedhom, Ramy Rotolo, Shannon M. Vogel, Rachel I. Booth, Christopher M. Blaes, Anne H. Virnig, Beth A. Dusetzina, Stacie B. Gupta, Arjun The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up |
title | The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up |
title_full | The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up |
title_fullStr | The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up |
title_full_unstemmed | The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up |
title_short | The least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up |
title_sort | least costly pharmacy for cancer supportive care medications over time: the logistic toxicity of playing catch up |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9745713/ https://www.ncbi.nlm.nih.gov/pubmed/36512134 http://dx.doi.org/10.1007/s00520-022-07472-x |
work_keys_str_mv | AT etteldorfandrew theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT sedhomramy theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT rotoloshannonm theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT vogelracheli theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT boothchristopherm theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT blaesanneh theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT virnigbetha theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT dusetzinastacieb theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT guptaarjun theleastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT etteldorfandrew leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT sedhomramy leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT rotoloshannonm leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT vogelracheli leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT boothchristopherm leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT blaesanneh leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT virnigbetha leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT dusetzinastacieb leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup AT guptaarjun leastcostlypharmacyforcancersupportivecaremedicationsovertimethelogistictoxicityofplayingcatchup |